Author Archive

Denovium teams up with Primordial Genetics

Posted by denovium

Primordial Genetics, a synthetic biology company, and Denovium Inc., an artificial intelligence company, are collaborating to develop novel and more efficient enzymes for DNA synthesis to ultimately impact the diagnosis, prevention and treatment of human diseases, such as cancer, heart disease, HIV and genetic diseases, such as cystic fibrosis. The research and development project is supported through a grant by the National Human Genome Research Institute of the National Institutes of Health.

Biocom’s 4th Annual Big Data Summit 2019

Posted by denovium

Our CSO, Gregory Hannum, covers our latest work on AI-guided protein discovery, evolution and de novo design.

SynBioBeta 2019: The Global Synthetic Biology Summit

Posted by denovium

Our CEO, Toby Richardson, will be presenting at SynBioBeta this year alongside Nobel Laureate Frances Arnold and many other leaders in the field!

San Diego, CA and Sunnyvale, CA

Posted by denovium

Denovium and Maxygen announced today the formation of a strategic partnership centered on the application of Denovium’s artificial intelligence (AI) platform to Maxygen’s molecular breeding technology.